Relevant nursing measures for the adverse reactions associated with chimeric antigen receptor T cells (CAR-T) immunotherapy: a systematic review of case reports†

by Zhang Xu, Sun Di, Jiang Gui-Chun
Published 2019-07-01

Chimeric Antigen Receptor (CAR) T Cell Therapy for Metastatic Melanoma: Challenges and Road Ahead

by Tahereh Soltantoyeh, Behnia Akbari, Amirali Karimi, Ghanbar Mahmoodi Chalbatani, Navid Ghahri-Saremi, Jamshid Hadjati, Michael R. Hamblin, Hamid Reza Mirzaei
Published 2021-06-01

Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors

by Giuseppe Schepisi, Vincenza Conteduca, Chiara Casadei, Giorgia Gurioli, Lorena Rossi, Valentina Gallà, Maria Concetta Cursano, Nicole Brighi, Cristian Lolli, Cecilia Menna, Alberto Farolfi, Salvatore Luca Burgio, Amelia Altavilla, Giovanni Martinelli, Ugo De Giorgi
Published 2020-09-01

GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma – assessing tumor and T cell interaction

by Jatuporn Sujjitjoon, Elias Sayour, Shih-Ting Tsao, Mongkol Uiprasertkul, Kleebsabai Sanpakit, Jassada Buaboonnam, Pa-thai Yenchitsomanus, La-ongsri Atchaneeyasakul, Lung-Ji Chang
Published 2021-02-01

Chimeric antigen receptor T-cell therapy in hematopoietic and nonhematopoietic malignancies

by Faizan Ahmad
Published 2020-01-01

Editorial: Exploiting the Immune System to Treat Multiple Myeloma: From Transplantation to Novel Treatment Approaches

by Niels W. C. J. van de Donk, Efstathios Kastritis, Francesca Gay
Published 2020-10-01

Review of Cancer Immunotherapy: Application of Chimeric Antigen Receptor T Cells and Programmed Death 1/Programmed Death-ligand 1 Antibodies

by Tengfei Zhang, Ling Cao, Zhen Zhang, Dongli Yue, Yu Ping, Hong Li, Lan Huang, Yi Zhang
Published 2015-01-01

Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM)

by Astero Klampatsa, Andrew R. Haas, Edmund K. Moon, Steven M. Albelda
Published 2017-09-01

Bispecific T Cell Engagers for the Treatment of Multiple Myeloma: Achievements and Challenges

by Kinan Alhallak, Jennifer Sun, Amanda Jeske, Chaelee Park, Jessica Yavner, Hannah Bash, Berit Lubben, Ola Adebayo, Ayah Khaskiah, Abdel Kareem Azab
Published 2021-06-01

Manipulating the Metabolism to Improve the Efficacy of CAR T-Cell Immunotherapy

by Marsha Pellegrino, Francesca Del Bufalo, Biagio De Angelis, Concetta Quintarelli, Ignazio Caruana, Emmanuel de Billy
Published 2021-12-01

Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer

by Jiang Lv, Ruocong Zhao, Di Wu, Diwei Zheng, Zhiping Wu, Jingxuan Shi, Xinru Wei, Qiting Wu, Youguo Long, Simiao Lin, Suna Wang, Zhi Wang, Yang Li, Yantao Chen, Qing He, Suimin Chen, Huihui Yao, Zixia Liu, Zhaoyang Tang, Yao Yao, Duanqing Pei, Pentao Liu, Xuchao Zhang, Zhenfeng Zhang, Shuzhong Cui, Ren Chen, Peng Li
Published 2019-02-01

Awakening immunity against cancer: a 2017 primer for clinicians

by Amit Jain, Qing Zhang, Han-Chong Toh
Published 2017-08-01

The functional verification of EGFR-CAR T-cells targeted to hypopharyngeal squamous cell carcinoma

by Dong Y, Ding Y, Guo W, Huang J, Yang Z, Zhang Y, Chen X
Published 2018-10-01

PSCA is a target of chimeric antigen receptor T cells in gastric cancer

by Di Wu, Jiang Lv, Ruocong Zhao, Zhiping Wu, Diwei Zheng, Jingxuan Shi, Simiao Lin, Suna Wang, Qiting Wu, Youguo Long, Peng Li, Yao Yao
Published 2020-01-01

Engineering better chimeric antigen receptor T cells

by Hao Zhang, Pu Zhao, He Huang
Published 2020-12-01

Combination of Interleukin-11Rα chimeric antigen receptor T-cells and programmed death-1 blockade as an approach to targeting osteosarcoma cells In vitro

by Hatel Rana Moonat, Gangxiong Huang, Pooja Dhupkar, Keri Schadler, Nancy Gordon, Eugenie Kleinerman
Published 2017-01-01

A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma

by Heng Mei, Chenggong Li, Huiwen Jiang, Xinying Zhao, Zhiping Huang, Dan Jin, Tao Guo, Haiming Kou, Lin Liu, Lu Tang, Ping Yin, Zhihui Wang, Lisha Ai, Sha Ke, Yimeng Xia, Jun Deng, Lei Chen, Li Cai, Chunyan Sun, Linghui Xia, Gaoquan Hua, Yu Hu
Published 2021-10-01

The Potential Role of the Intestinal Micromilieu and Individual Microbes in the Immunobiology of Chimeric Antigen Receptor T-Cell Therapy

by Maria-Luisa Schubert, Roman Rohrbach, Michael Schmitt, Christoph K. Stein-Thoeringer, Christoph K. Stein-Thoeringer
Published 2021-05-01

PD-1 disrupted CAR-T cells in the treatment of solid tumors: Promises and challenges

by Eileen McGowan, Qimou Lin, Guocai Ma, Haibin Yin, Size Chen, Yiguang Lin
Published 2020-01-01

JAK-STAT Domain Enhanced MUC1-CAR-T Cells Induced Esophageal Cancer Elimination

by Zhang H, Zhao H, He X, Xi F, Liu J
Published 2020-10-01